跳到正文
原文
Nature 健康护理主题·· 2026-10-14AI 评分35

拉丁美洲和加勒比地区痴呆研究优先事项:多国利益相关者调查结果

Dementia research priorities in Latin America and the Caribbean: findings from a multi-country stakeholder survey

AI 导读

研究通过覆盖25个国家的横断面在线调查,确定了拉丁美洲和加勒比地区痴呆研究的优先领域。842名利益相关者从11个预设领域中选出并排序5个,以识别共同及特定群体的研究优先事项。该首次多国立利益相关者优先设定过程旨在解决现有全球框架未能充分反映该地区流行病学及社会文化多样性的证据缺口。

正文

Introduction

Dementia represents one of the most pressing public health challenges of the 21st century. More than 57 million people worldwide are currently living with dementia, a number projected to reach 152 million by 2050, with profound implications for individuals, families, and health systems1,2. The burden of dementia is not only increasing in magnitude but also in complexity, reflecting the interaction of demographic ageing, social determinants of health, and inequities in access to care. Latin America and the Caribbean (LAC) is expected to experience one of the fastest increases in dementia prevalence globally, rising from approximately 7.8 million cases to over 27 million by mid-century3,4,5,6. Recent epidemiological studies further indicate that several countries in the region are experiencing a rapid increase in dementia prevalence and burden, reinforcing the urgency of strengthening prevention, early diagnosis, and health-system preparedness7. This rapid growth is occurring in the context of poor dementia awareness, absence of prevention programs, fragmented health systems, limited specialist services, and insufficient long-term care infrastructure, posing significant challenges for timely diagnosis, continuity of care, and support for affected individuals and their families2,7,8.

Historically, dementia research agendas have been largely shaped by academic institutions, funding bodies, and industry stakeholders, with comparatively limited integration of the perspectives of those most directly affected by the condition. In recent years, stakeholder-engaged approaches to research prioritization, including patient and public involvement initiatives, have sought to address this imbalance by incorporating experiential knowledge into the research priority-setting process. These initiatives have also shown that research priorities may vary according to the perspectives and responsibilities of different stakeholder groups, underscoring the importance of incorporating multiple perspectives into research agenda setting8,9,10. This consideration is particularly relevant in Latin America and the Caribbean, where substantial heterogeneity in demographic transition, health-system capacity, and sociocultural contexts may shape perceptions of dementia research needs and priorities.

At the same time, evidence from international dementia research prioritization exercises indicates that dementia research priorities are not uniform across settings but are shaped by local epidemiological, structural, and socio-cultural contexts9,10,11. Systematic reviews of international prioritization exercises have identified common research domains, including care, diagnosis, and treatment10,11,12,13, while also demonstrating substantial variation in their relative importance across countries and stakeholder groups11,12,13. High-income countries often prioritize optimization of care systems and post-diagnostic support, whereas low- and middle-income regions place greater emphasis on awareness, education, and access to basic services12˒13,14. These differences reflect diverse cultural understandings of dementia and varying stages of health-system development and resource availability, reinforcing the need for regionally informed prioritization efforts. Taken together, this evidence indicates that dementia research priorities vary along two related axes: who is asked, and where they are asked, both of which must be examined together to build a regionally relevant research agenda.

Despite the growing burden of dementia and increasing international efforts to establish dementia research priorities, there remains limited empirical evidence on how these priorities are valued across different stakeholder groups in Latin America and the Caribbean (LAC). Existing global frameworks and previous research prioritization initiatives, including the World Health Organization (WHO) Dementia Research Blueprint, provide an important foundation but may not fully reflect the epidemiological, health-system, and socio-cultural diversity of the region or the perspectives of stakeholders directly involved in dementia research, care, advocacy, and policy9,10,11,12,13,14,15,16,17. This evidence gap limits the development of regionally informed research agendas that are responsive to the priorities and needs of those involved in dementia care, research, and policy. To our knowledge, this is the first multi-country stakeholder-engaged prioritization exercise conducted across Latin America and the Caribbean using a common framework to examine both shared and stakeholder-specific dementia research priorities.

We conducted a cross-sectional, stakeholder-engaged online survey in which participants across 25 countries selected and ranked five of eleven predefined dementia research domains to identify shared and stakeholder-specific dementia research priorities for the region.

Results

Characteristics of participants across stakeholder groups

The analytical sample included 842 respondents recruited through a non-probabilistic, network-based sampling strategy across 25 countries (Fig. 1). Most participants resided in Central America and the Caribbean (60.8%), followed by South America (36.3%), whereas a small proportion were Latin American participants residing in North America or Europe (2.9%) (Table 1). The largest national contributions were from Mexico (15.0%), Cuba (13.0%), Guatemala (11.5%), Colombia (8.9%), the Dominican Republic (8.4%), Ecuador (8.0%), and Costa Rica (7.7%). Most responses were completed in Spanish (93.6%), followed by Portuguese (3.9%) and English (2.5%).

Fig. 1: Country of residence of the participants.

Map showing the geographic distribution of the 842 participants included in the dementia research prioritization survey. Countries are shaded according to the number of respondents from each country. The inset provides an enlarged view of Central America and the Caribbean. Grey areas indicate countries with no participants or for which no survey data was available.

Table 1 Characteristics of participants in the dementia research priorities survey

Full size table

Stakeholder roles included general public (28.6%), caregivers (22.7%), healthcare professionals (24.1%), researchers (21.6%), policymakers (1.6%), and people living with cognitive impairment or dementia (1.3%). These role categories were not mutually exclusive, as some participants identified with more than one stakeholder role. However, for analytical purposes, each participant was assigned to a single primary stakeholder profile according to the predefined classification described in the Methods section. The Sankey diagram (Fig. 2) illustrates the flow from self-identified roles to primary profile assignments.

Fig. 2: Sankey diagram of participant roles and primary stakeholder classification.

Diagram illustrating how respondents reporting overlapping self-identified stakeholder roles were assigned to a single primary stakeholder group for analysis. The right panel displays all self-reported stakeholder-role combinations (n = 924), reflecting that some respondents identified with more than one stakeholder role. The centre panel shows the final analytical sample of unique participants (n = 842). The width of each flow is proportional to the number of respondents represented.

The overall mean age was 47.5 years (SD 14.9), with variation across stakeholder groups. People living with dementia had the highest mean age (68.6 ± 10.4 years), whereas healthcare professionals and members of the general public were younger on average (45.1 ± 12.7 and 44.6 ± 17.3 years, respectively). The sample was predominantly female (73.2%), particularly among caregivers (80.5%) and researchers (78.5%). Most participants (89.9%) had completed university or postgraduate education, although educational attainment varied across stakeholder groups. Postgraduate education was most frequent among healthcare professionals (71.7%), policymakers (56.8%), and researchers (56.4%), whereas people living with dementia more commonly reported secondary or university education. (Table 1)

Prevention and early diagnosis were the highest-ranked research priorities

Prevention and risk reduction was the most frequently selected research priority overall, followed by early and accurate diagnosis (Table 2). Prevention and risk reduction was ranked first by 449 respondents (54.0%) and was included among the top three priorities by 577 (69.4%). Early and accurate diagnosis was the second highest-ranked research priority, ranked first by 120 respondents (14.4%) and included among the top three priorities by 441 (53.0%).

Table 2 Overall prioritization of predefined dementia research domains. †

Full size table

After these two leading domains, the next most frequently selected research priorities were development of pharmacological treatments (ranked first by 51 respondents, 6.1%; top three in 252, 30.3%), understanding biological mechanisms (39, 4.7%; top three in 154, 18.5%), and person-centred care (35, 4.2%; top three in 169, 20.3%).

Table 2 summarizes the distribution of participants selecting each predefined research domain as their first priority and the proportion including each domain among their three highest-ranked priorities and among all five ranked priorities. Because respondents ranked only five of the eleven predefined research domains, the percentages reported for the top three and top five categories describe the frequency with which each domain was included within participants’ ranked selections and should not be interpreted as cumulative percentages across all research domains.

Research priority rankings across stakeholder groups

Table 3 presents the weighted priority scores for the predefined dementia research domains according to stakeholder group. Across all stakeholder groups, prevention and risk reduction and early and accurate diagnosis consistently received the highest weighted priority scores, indicating a high degree of consistency in research prioritization across stakeholders. The five highest-priority research domains together accounted for between 63.9% and 70.9% of the total weighted priority scores within each stakeholder group, indicating that research priorities were concentrated within a relatively small number of predefined research domains.

Table 3 Weighted priority scores (%) for predefined dementia research domains according to stakeholder group

Full size table

The overall ranking of research priorities showed a high degree of agreement across the four principal stakeholder groups (Kendall’s W = 0.925), with all pairwise Spearman correlation coefficients ≥0.87 (all p < 0.001). Prevention and risk reduction accounted for the largest proportion of responses across all stakeholder groups (18.4%–21.0%), followed by early and accurate diagnosis (15.1–17.1%)

Secondary priorities varied modestly across stakeholder groups. Healthcare professionals placed greater emphasis on pharmacological treatments (12.5%), whereas researchers distributed their responses more evenly between pharmacological treatments (9.3%) and non-pharmacological interventions (10.4%). Caregivers assigned relatively greater importance to person-centred care (10.5%) and pharmacological treatments (9.9%). Policymakers placed comparatively greater emphasis on education and training (13.0%) and person-centred care (10.9%), alongside prevention and early diagnosis. Technology and innovation (2.2–4.3%) and care environments (3.6%–6.6%) consistently accounted for the smallest proportion of responses across all stakeholder groups.

In the domain-specific exploratory analyses, 9 of the 11 predefined research domains showed no statistically significant differences across the four principal stakeholder groups. Pharmacological treatments showed the strongest evidence of between-group variation (χ² = 21.25, df = 3, p < 0.001, Cramér’s V = 0.161). Bonferroni-corrected post-hoc analyses identified significant differences between healthcare professionals and the general public (53.2% vs. 32.4%, p < 0.001) and between healthcare professionals and researchers (53.2% vs. 36.8%, p = 0.002), indicating that healthcare professionals selected this domain more frequently than these two stakeholder groups.

Education and training showed an overall significant association (χ² = 8.89, p = 0.031); however, no pairwise comparison remained statistically significant after Bonferroni correction. Prevention and risk reduction and early and accurate diagnosis showed no statistically significant differences across stakeholder groups (p = 0.78 and p = 0.45, respectively), indicating that these priorities were highly consistent across the stakeholder groups represented in the study.

Research priorities according to gender and age

Differences in research priorities according to gender and age are summarised below. Gender was associated with significant differences in five of the eleven predefined research domains. Male respondents were more likely to select understanding biological mechanisms (31.5% vs. 20.6%, p = 0.001) and development of pharmacological treatments (47.5% vs. 36.9%, p = 0.006), whereas female respondents more frequently prioritised care environments (23.7% vs. 14.2%, p = 0.037), education and training (29.5% vs. 21.5%, p = 0.003), and person-centred care (39.4% vs. 31.5%, p = 0.021). No statistically significant gender differences were observed for prevention and risk reduction or early and accurate diagnosis (p = 0.18 and p = 0.55, respectively), indicating that these priorities were consistent across both women and men (Supplementary Table 1).

Age was significantly associated with two research domains. Selection of pharmacological treatments decreased progressively across older age groups, from 47.7% among respondents aged 36–50 years to 26.9% among those aged ≥66 years (χ² = 21.51, p < 0.001). Selection of non-pharmacological interventions also differed significantly across age groups (χ² = 9.00, p = 0.029). In contrast, prevention and risk reduction and early and accurate diagnosis remained consistent across all age groups, with no statistically significant differences (p = 0.99 and p = 0.38, respectively).

Research priorities across LAC subregions

The distribution of research priorities was highly similar across the two major Latin American and Caribbean subregions. Geographic groupings were used for descriptive and exploratory comparisons and should not be interpreted as implying epidemiological, demographic, socioeconomic, or health-system homogeneity within each subregion. The overall pattern of priorities was consistent between Central America and the Caribbean (n = 512) and South America (n = 306) (Supplementary Table 2). Prevention and risk reduction remained the highest-ranked priority in both subregions (70.3% vs. 71.2%), followed by early and accurate diagnosis (55.4% vs. 51.9%).

The distribution of secondary priorities was also comparable between subregions, including development of pharmacological treatments (31.5% vs. 34.6%), person-centred care (28.2% vs. 30.2%), and non-pharmacological interventions (26.9% vs. 30.4%). No statistically significant differences were identified for any of the predefined research domains (all p > 0.05), indicating a high degree of consistency in stakeholder priorities across the major LAC subregions.

Discussion

In this multi-country stakeholder survey, prevention and early diagnosis emerged as the leading priorities for dementia research and care across Latin America and the Caribbean. Although strong convergence was observed for these two core domains, variation in secondary priorities across stakeholder groups highlights the multidimensional nature of dementia and the need for integrated research agendas that bridge biomedical, care, and health-system perspectives. Rather than reflecting competing priorities, these differences appear to represent complementary perspectives across the dementia research ecosystem.

The prominence of prevention and early diagnosis reflects both epidemiological realities and structural constraints in the region. LAC faces a high burden of modifiable risk factors alongside persistent gaps in diagnostic capacity, workforce availability, and continuity of care. Dementia remains substantially underdiagnosed and is often identified at advanced stages, limiting opportunities for timely intervention, care planning, and risk reduction6,8,18. Recent evidence further indicates that dementia prevalence continues to increase across several countries in Latin America and the Caribbean, reinforcing the urgency of strengthening prevention and early diagnosis within regional health systems7,18. In this context, prioritizing risk reduction and early detection represents both a clinical and a pragmatic response to health-system limitations. The consistent prioritization of these domains across the stakeholder groups represented in this study suggests that prevention and early diagnosis are widely perceived as important areas for future research and implementation; however, the sampling characteristics of the study preclude interpreting this agreement as population-level or region-wide consensus. Successful implementation will also require parallel investments in workforce capacity, diagnostic infrastructure, and equitable access to care to avoid widening existing health-system gaps.

This prioritization pattern aligns with global frameworks, including the World Health Organization dementia research blueprint, the WHO Global Action Plan on the Public Health Response to Dementia, and the WHO Integrated Care for Older People (ICOPE) framework, which emphasize prevention, diagnosis, and health-system strengthening9,15,19.

The pattern observed in this study also complements previous international research-prioritization exercises, although some differences are apparent. Studies conducted in Europe and other high-income settings have generally placed greater emphasis on post-diagnostic support, quality of life, maintenance of independence, and caregiver support, particularly when people living with dementia and family caregivers represented a larger proportion of participants11,12,13,14,20,21. These contrasts reinforce the context-dependent nature of research prioritization and highlight the importance of generating region-specific evidence rather than assuming that priorities identified elsewhere necessarily reflect the needs of LAC.

From an epidemiological perspective, the emphasis on prevention in LAC is well supported. First, population-attributable fraction analyses suggest that up to 57% of dementia cases in the region may be attributable to modifiable risk factors22,23,24,25,26,27,28, a proportion higher than in many high-income settings. This evidence provides a strong public health rationale for prioritising prevention within regional dementia research agendas. In parallel, the expansion of regional initiatives focused on multidomain interventions reflects growing scientific and policy attention to prevention as a feasible and scalable strategy29,30. Recent findings from the LatAm-FINGERS initiative further support the feasibility of implementing culturally adapted multidomain interventions across diverse Latin American populations, reinforcing prevention as an achievable component of future dementia strategies30

Variation in secondary priorities across stakeholder groups provides important insight into how different forms of knowledge shape research agendas. Researchers and healthcare professionals emphasized pharmacological treatments and biological mechanisms, whereas caregivers and the general public prioritized person-centered care and non-pharmacological interventions. Policymakers highlighted workforce development and system capacity. Rather than representing conflicting priorities, these stakeholder-specific patterns indicate complementary perspectives that may help shape balanced research portfolios integrating biomedical, clinical, social, and health-system dimensions of dementia.

An additional dimension of variation emerged in relation to gender. Female respondents showed stronger endorsement of care-oriented priorities, including person-centered care, care environments, and education, while male respondents were more likely to prioritize biomedical domains such as pharmacological treatments and biological mechanisms. These differences were statistically significant for five of eleven domains and were more pronounced than differences across professional roles. These gender-related differences should be interpreted cautiously, since caregiving responsibilities, professional roles, and gender are likely to be interrelated, and no multivariable analyses were performed. Given that the dementia caregiving workforce in LAC is predominantly female, and that women constitute the majority of informal caregivers globally, these gendered orientations may have practical implications for how priorities are translated into policies and programs of care. The stability of prevention and diagnosis across genders suggests that these priorities transcend both professional and demographic boundaries.

Although technology was recognized as relevant, it was consistently ranked as a lower research priority across stakeholder groups. This pattern should not necessarily be interpreted as indicating limited perceived relevance of technology itself. Rather, respondents may have conceptualised technological innovation primarily as an enabling tool for prevention, diagnosis, care delivery, caregiver support, or service organisation rather than as a stand-alone research priority. In addition, unequal access to digital infrastructure and implementation capacity across LAC settings may have influenced its relative prioritisation compared with prevention, diagnosis, workforce development, and person-centred care. These interpretations remain exploratory, and future qualitative studies may help clarify how different stakeholder groups conceptualise the role of technology within dementia research and healthcare delivery.

This study has several strengths, including its large multi-country sample and the inclusion of diverse stakeholder groups across the research–care–policy spectrum. The stakeholder-engaged approach enhances the relevance and applicability of the findings. The participation of respondents from 25 countries provides one of the broadest stakeholder-based overviews of dementia research priorities currently available for Latin America and the Caribbean, while also illustrating the feasibility of conducting region-wide priority surveys through collaborative research networks. However, several limitations should be acknowledged.

First, the online survey design and recruitment through professional, advocacy, and civil society networks resulted in a highly educated sample (89.9% university or postgraduate education). Notably, this pattern was observed across nearly all stakeholder groups, including caregivers and members of the general public, suggesting that it cannot be explained solely by the inclusion of healthcare professionals, researchers, and policymakers. Rather, the online convenience sampling strategy and dissemination through existing dementia-related networks are likely to have preferentially reached individuals with higher educational attainment, greater digital access, and stronger engagement with dementia-related issues. Consequently, participation from individuals with lower educational attainment, rural and Indigenous communities, and populations with limited access to digital technologies was likely reduced. The predominance of Spanish-language responses (93.6%), together with the comparatively low proportion of Portuguese-language responses (3.9%), also limits the regional balance of the sample, particularly given the demographic and scientific importance of Brazil within LAC. Accordingly, the findings should not be interpreted as proportionally representing the linguistic or population distribution of the region; instead, they reflect the perspectives of a large stakeholder-based sample rather than those of the general population of Latin America and the Caribbean.

Second, people living with dementia were substantially underrepresented, and notably, none completed the priority-ranking section of the survey. This means that the group whose lived experience is most central to person-centred research had no direct voice in the study’s principal outcome. This limitation has also been recognized in previous international prioritisation initiatives and reflects the methodological challenges associated with engaging people living with dementia in complex survey-based exercises10,11,12,13. Future studies should employ adapted methods, such as facilitated interviews, simplified survey instruments, proxy-supported participation where appropriate, and other participatory approaches to ensure meaningful inclusion of people living with dementia while preserving their autonomy and preferences. Despite this limitation, the study provides one of the largest stakeholder-based assessments of dementia research priorities conducted across Latin America and the Caribbean to date. Participatory frameworks, including Theory of Change approaches implemented within regional initiatives such as STRiDE, may provide useful models for strengthening stakeholder engagement in future priority-setting exercises31,32,33.

Third, although respondents were recruited from 25 countries, participation was not evenly distributed across the region. Differences in sample size between countries probably reflect variation in the availability of collaborating institutions, national dementia networks, and dissemination capacity rather than differences in stakeholder priorities. Nevertheless, the consistency observed across the major geographical subregions suggests that the principal patterns extend across diverse LAC contexts, although future country-specific prioritisation exercises would further strengthen the regional evidence base.

Fourth, the prioritization exercise was based on eleven predefined research domains rather than allowing participants to generate priorities de novo. This standardized framework facilitated comparisons across countries and stakeholder groups but may have constrained the identification of priorities arising from specific local contexts. Issues such as stigma, barriers to access, workforce shortages, inequalities in care, or the needs of underserved populations may therefore be embedded within broader domains or may not have been fully captured by the survey. Future priority-setting studies could complement standardized ranking frameworks with open-ended, qualitative, or deliberative approaches to identify context-specific priorities that may not be represented within predefined domains.

Beyond identifying research priorities, the observed patterns also have practical implications for research funding and health policy. The consistent prioritisation of prevention and early diagnosis suggests that future regional investment should continue strengthening multidomain risk-reduction strategies, culturally appropriate early detection programmes, implementation research, and capacity building within primary healthcare systems. At the same time, variation in secondary priorities indicates that future research agendas should maintain an appropriate balance between biomedical discovery, person-centred care, non-pharmacological interventions, workforce development, and health-system strengthening. Such an integrated approach is likely to be more responsive to the heterogeneous needs of people living with dementia, their families, healthcare professionals, and policymakers throughout the region.

These priorities should also be considered within the context of ongoing regional collaborative initiatives that are already strengthening dementia research, prevention, diagnosis, and implementation across Latin America and the Caribbean. Collaborative platforms including the 10/66 Dementia Research Group7,34 Alzheimer Association8, Alzheimer IberoAmerica, the Latin America and Caribbean Consortium on Dementia (LAC-CD), ReDLat4,35, LatAm-FINGERS30, and STRiDE33 provide important opportunities to translate research into practice while strengthening regional scientific capacity and international collaboration. The priorities identified in this survey broadly align with the objectives of these initiatives and may contribute to informing future collaborative research programmes, funding priorities, and implementation strategies across the region.

To our knowledge, this is the first cross-sectional multi-country stakeholder-engaged prioritization exercise conducted across Latin America and the Caribbean using a common prioritization framework aligned with the WHO Dementia Research Blueprint15. Across stakeholder groups, prevention and risk reduction and early and accurate diagnosis emerged as the leading priorities, while secondary priorities varied according to stakeholder profile. Taken together, the results provide stakeholder-informed evidence on dementia research priorities across Latin America and the Caribbean. The consistent prioritisation of prevention and early diagnosis, together with complementary differences in secondary priorities, may help inform future regional research agendas, funding strategies, and policy development while supporting ongoing collaborative efforts to strengthen dementia prevention, diagnosis, care, and health-system preparedness throughout the region.

This cross-sectional multi-country stakeholder-engaged research prioritization study identifies prevention and risk reduction and early and accurate diagnosis as highly consistent research priorities across the stakeholder groups represented in this LAC sample, while also revealing complementary stakeholder-specific priorities. Translating these priorities into research agendas will require culturally and contextually adapted prevention strategies, feasible pathways for earlier detection and diagnosis within primary healthcare, workforce capacity building, and integration of person-centred care and caregiver support. Together, these findings may inform research investment, national dementia strategies, and regional collaboration, while implementation priorities should remain responsive to the substantial health-system, socioeconomic, and cultural diversity across LAC.

Methods

Study design

We conducted a cross-sectional, multi-country stakeholder-engaged research prioritization study using an online survey distributed across Latin America and the Caribbean (LAC). The study aimed to identify how predefined dementia research domains were prioritized across different stakeholder groups in the region. The study followed a multi-phase design integrating a structured review of the literature, stakeholder consultation, and survey-based prioritization. The survey design and prioritization process consisted of the following steps: (1) identifying dementia research domains from the literature; (2) submitting the proposed research domains and survey content to key stakeholders for feedback; (3) creating and pilot testing an online survey available in Spanish, Portuguese, and English; (4) disseminating the survey through key stakeholders and civil society organizations; and (5) analyzing the results. The survey was disseminated through professional and academic networks, Alzheimer associations, and social media channels. The study was designed to characterize stakeholder priorities within a predefined research framework rather than to establish formal consensus or generate clinical or policy recommendations. This process is summarized in Fig. 3.

Fig. 3: Research process sequence.

Research process sequence. Overview of the sequential phases of the stakeholder-engaged research prioritization study, including identification of dementia research domains through a structured literature review and international policy frameworks, stakeholder consultation, survey development and pilot testing, regional survey dissemination, and quantitative analysis of stakeholder responses.

Participants and recruitment

Eligible participants were adults aged ≥18 years residing in LAC or individuals of Latin American origin living abroad. Participation was voluntary, anonymous, and no personal identifying information was collected. Recruitment followed a non-probabilistic, convenience sampling approach. A total of 842 participants from 25 Latin American and Caribbean countries were included after processing 896 responses and excluding the following: eleven responses from the pilot study, five individuals who did not provide informed consent, 17 duplicate records, and 21 responses with incomplete information about research priorities (Fig. 4). Because the objective of the study was to identify dementia research priorities among stakeholders directly involved in dementia research, care, advocacy, and policy, recruitment intentionally targeted these stakeholder groups rather than the general population. People living with cognitive impairment or dementia were eligible and were intentionally included among the target stakeholder groups; however, no specific adaptations to the online priority-ranking procedure were implemented for participants with cognitive impairment.

Fig. 4: Study participants Flow diagram of participants in Latin America and the Caribbean.

Flow diagram of study participants. Flowchart illustrating participant recruitment, eligibility assessment, exclusions, and the final analytical sample of stakeholders from 25 Latin American and Caribbean countries included in the research prioritization survey.

During the survey, participants were asked key questions to determine their primary role in relation to dementia. Except for people living with dementia and members of the general public, when more than one profile was identified, the principal stakeholder category was assigned according to the response to the question “Main occupation?” included in the first section of the survey.

Identification of research priority areas

Research priority areas were identified through a structured review of scientific literature and global dementia policy frameworks, including the World Health Organization (WHO) Dementia Research Blueprint9,15. The objective of this review was to identify dementia research domains that had been consistently recognised across published research prioritization exercises and international policy frameworks rather than to undertake a formal systematic review.

Eleven core research domains were identified: prevention and risk reduction; biological mechanisms; pharmacological treatments; non-pharmacological interventions; early and accurate diagnosis; quality of life; person-centred care; care environments; professional skills development; technology and innovation; and health policy and systems. (Supplementary Table 3)

These predefined research domains constituted the conceptual framework for the subsequent stakeholder prioritization exercise and remained unchanged throughout survey development, pilot testing, and data collection.

Survey development and pilot testing

The survey was developed by a regional steering committee and refined by a 12-member expert panel, including clinicians, researchers, caregivers, and one person living with dementia. The expert panel reviewed the proposed research domains, questionnaire structure, wording, clarity, and overall content to improve its relevance and applicability across stakeholder groups.

The instrument was pilot tested to assess clarity and feasibility, with minor revisions implemented. These revisions were limited to wording, questionnaire navigation, and usability and did not modify the predefined research domains or the prioritization framework.

The final questionnaire included sections on participant characteristics and a prioritization exercise in which respondents selected and ranked five of the eleven research domains they considered most important. Participants ranked only their five highest priorities.

The ranking process was facilitated by a drop-down list interface, which minimized the potential influence of the initial order in which response options were presented. The survey was available in Spanish, Portuguese, and English, with back-translation to ensure conceptual consistency across languages.

Stakeholder engagement and consultation related to the identification of domains and survey refinement

To ensure contextual relevance, multiple stakeholder engagement activities were conducted. These included consultations with regional networks such as the 10/66 Dementia Research Group, Alzheimer Iberoamérica (AIB), the Latin American and Caribbean Consortium on Dementia (LAC-CD), and the LATAM-FINGERS network. Structured discussions were held with dementia researchers from Cuba, the Dominican Republic, Mexico, Peru, and Venezuela.

In addition, two stakeholder consultation workshops were conducted during AIB meetings in Santa Cruz, Bolivia (November 2024), and Ibiza, Spain (November 2025). The Santa Cruz workshop contributed to the review of the clarity, wording, and contextual relevance of the survey instrument before data collection began. The Ibiza workshop provided additional stakeholder feedback during the data-collection period but did not result in modifications to the survey instrument, predefined research domains, or prioritization framework. Thus, the eleven predefined research domains and the prioritization procedure remained unchanged throughout data collection.

Additional input was obtained from Alzheimer associations, scientific committees, and stakeholder advisory groups.

Data collection

Data were collected between June 11, 2025, and January 12, 2026, using an online questionnaire. Participants selected and ranked the research domains they considered most important. Responses were anonymized and stored in a protected database. The participant flow is presented in Fig. 4.

Data analysis

Descriptive statistics were used to summarize participant characteristics and response distributions. Overall research priorities were described according to the frequency with which each predefined research domain was selected as the first priority, among the top three priorities, and among the top five priorities. Participants could report more than one stakeholder role; all endorsed roles were retained for descriptive reporting, whereas each participant was assigned to a single primary analytical profile for stakeholder-group comparisons, as described above.

Between-group differences in the proportion of participants selecting each research domain were assessed using Pearson’s chi-square tests of independence (four-group comparisons across caregivers, healthcare professionals, researchers, and members of the general public; policymakers and people living with dementia or cognitive impairment were excluded because of their small analytical sample sizes). Additional chi-square tests examined differences according to gender (female versus male) and age group (19–35, 36–50, 51–65, and ≥66 years). Bonferroni-adjusted pairwise comparisons were conducted when the overall chi-square test was statistically significant. Because participants selected five of eleven domains, domain-specific comparisons were interpreted as exploratory; no additional correction for multiple testing was applied across the eleven domain-level tests.

For ordinal priority rankings, Kruskal–Wallis H tests were used, followed by Bonferroni-adjusted pairwise comparisons when the overall test was statistically significant.

To compare overall prioritization patterns across stakeholder groups, a weighted priority score was calculated for each research domain. Participants ranked their five highest-priority research domains, assigning an ordinal ranking from first to fifth. Rankings were weighted using a five-point scale (5 points for the first priority, 4 for the second, 3 for the third, 2 for the fourth, and 1 for the fifth). For each stakeholder group, weighted scores were summed across all participants and expressed as percentages of the total weighted score, allowing comparison of the relative importance assigned to each research domain across stakeholder groups.

Agreement in the overall ranking of priorities across caregivers, healthcare professionals, researchers, and members of the general public was evaluated using Kendall’s coefficient of concordance (Kendall’s W), with pairwise agreement assessed using Spearman’s rank correlation coefficients. Geographic groupings were used for descriptive and exploratory comparisons and should not be interpreted as implying epidemiological, demographic, socioeconomic, or health-system homogeneity within each subregion. A two-sided p value < 0.05 was considered statistically significant. All statistical analyses were performed using IBM SPSS Statistics, version 28 (IBM Corp., Armonk, NY, USA).

Ethical considerations

The study was approved by the Research Ethics Committee of the National Institute of Neurology and Neurosurgery, Mexico (IRB approval No. 130/25). All participants provided informed consent before participation. The study did not involve clinical interventions, and no identifiable or sensitive personal data were collected. Participants were free to withdraw at any time.

Data availability

The datasets generated and/or analyzed during this study are not publicly available due to institutional and ethical restrictions but are available from the corresponding author on reasonable request. Data are stored securely at the Laboratory of Dementias, National Institute of Neurology and Neurosurgery, National Autonomous University of Mexico.

Code availability

This study did not involve the development of custom code or software. All statistical analyses were performed using standard functions available in SPSS v.28.

References

  1. Nichols, E. et al. GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7, e105–e125 1016/S2468-2667(21)00249-8 (2022).

  2. Alzheimer’s Disease International. World Alzheimer Report 2025: Reimagining Life with Dementia—The Power of Rehabilitation https://www.alzint.org/resource/world-alzheimer-report-2025/ (Alzheimer’s Disease International, 2025).

  3. Economic Commission for Latin America and the Caribbean. Demographic Observatory 2024: Population Prospects and Rapid Demographic Changes in Latin America and the Caribbean https://www.cepal.org/en/publications/81085 (ECLAC, 2024).

  4. Parra, M. A. et al. Dementia in Latin America: assessing the present and envisioning the future. Neurology 90, 222–231 https://doi.org/10.1212/WNL.0000000000004897 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Nitrini, R., Barbosa, M. T., Brucki, S. M. D., Yassuda, M. S. & Caramelli, P. Current trends and challenges on dementia management and research in Latin America. J. Glob. Health 10, 010362 https://doi.org/10.7189/jogh.10.010362 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Llibre-Guerra et al. Social determinants of health but not global genetic ancestry predict dementia prevalence in Latin America. Alzheimer’s Dement. 20, 4828–4840 https://doi.org/10.1002/alz.14041 (2024).

    Article  Google Scholar 

  7. Llibre-Guerra J. J. et al. Trends in dementia prevalence across Latin America and the Caribbean. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2026.2305 (2026).

  8. Suemoto, C. K. et al. The landscape of dementia research, diagnosis, treatment, and care in Latin America. Alzheimers Dement. 22, e71309 https://doi.org/10.1002/alz.71309 (2026).

    Article  PubMed  PubMed Central  Google Scholar 

  9. World Health Organization. Global Action Plan on the Public Health Response to Dementia 2017–2025 https://iris.who.int/handle/10665/259615 (World Health Organization, 2017).

  10. Logan, M., Leitch, S., Bosakh, Z., Beishon, L. & Quinn, T. J. Comparing international dementia research priorities: systematic review. Int. J. Geriatr. Psychiatry 37, 1–8 https://doi.org/10.1002/gps.5836 (2022).

    Article  Google Scholar 

  11. Kelly, S. et al. Dementia priority setting partnership with the James Lind Alliance: using patient and public involvement and the evidence base to inform the research agenda. Age Ageing 44, 985–993 https://doi.org/10.1093/ageing/afv143 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  12. Bethell, J. et al. Patient and public involvement in identifying dementia research priorities. J. Am. Geriatr. Soc. 66, 1608–1612 https://doi.org/10.1111/jgs.15453 (2018).

    Article  PubMed  Google Scholar 

  13. Ghosh, M., Chejor, P., Baker, M. & Porock, D. A systematic review of dementia research priorities. J. Geriatr. Psychiatry Neurol. 37, 343–354 https://doi.org/10.1177/08919887241232647 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  14. Shah, H. et al. Research priorities to reduce the global burden of dementia by 2025. Lancet Neurol. 15, 1285–1294 https://doi.org/10.1016/S1474-4422(16)30235-6 (2016).

    Article  PubMed  Google Scholar 

  15. World Health Organization. A Blueprint for Dementia Research https://iris.who.int/handle/10665/363341 (World Health Organization, 2022).

  16. Jackson, T. et al. Patient and public involvement in research: from tokenistic box ticking to valued team members. BMC Med. 18, 79 https://doi.org/10.1186/s12916-020-01544-7 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Livingston, G. et al. Dementia prevention, intervention, and care: 2024 report of the Lancet Standing Commission. Lancet 404, 572–628 https://doi.org/10.1016/S0140-6736(24)01296-0 (2024).

    Article  PubMed  Google Scholar 

  18. Parra, M. A. et al. Dementia in Latin America: paving the way toward a regional action plan. Alzheimers Dement. 17, 295–313 https://doi.org/10.1002/alz.12202 (2021).

    Article  PubMed  Google Scholar 

  19. World Health Organization. Integrated Care for Older People (ICOPE) Implementation Framework: Guidance for Systems and Services https://iris.who.int/handle/10665/325669 (World Health Organization, Geneva, 2019).

  20. Babulal, G. M. et al. Identifying gaps and barriers in Alzheimer’s disease and related dementia research and management in low- and middle-income countries: a survey of health professionals and researchers. J. Alzheimers Dis. 101, 1307–1320 https://doi.org/10.3233/JAD-240650 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  21. Patel, N. K. et al. Engaging multi-stakeholder perspectives to identify dementia care research priorities. J. Patient Rep. Outcomes 5, 46 https://doi.org/10.1186/s41687-021-00325-x (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  22. Calandri, I. L. et al. Sex and socioeconomic disparities in dementia risk: a population-attributable fraction analysis in Argentina. Neuroepidemiology 58, 264–275 https://doi.org/10.1159/000536524 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  23. Da Ros, L. U. et al. Social and health disparities associated with healthy brain ageing in Brazil and in other Latin American countries. Lancet Glob. Health 13, e277–e284 https://doi.org/10.1016/S2214-109X(24)00451-0 (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  24. Suemoto, C. K. et al. The potential for dementia prevention in Brazil: a population attributable fraction calculation for 14 modifiable risk factors. Lancet Reg. Health Am. 49, 101209 https://doi.org/10.1016/j.lana.2025.101209 (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  25. Stephan, B. C. M. et al. Population attributable fractions of modifiable risk factors for dementia: a systematic review and meta-analysis. Lancet Healthy Longev. 5, e406–e421 https://doi.org/10.1016/S2666-7568(24)00061-8 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  26. Mukadam, N., Sommerlad, A., Huntley, J. & Livingston, G. Population attributable fractions for risk factors for dementia in low-income and middle-income countries: an analysis using cross-sectional survey data. Lancet Glob. Health 7, e596–e603 https://doi.org/10.1016/S2214-109X(19)30074-9 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  27. Paradela, R. S. et al. Population attributable fractions for risk factors for dementia in seven Latin American countries: an analysis using cross-sectional survey data. Lancet Glob. Health 12, e1600–e1610 https://doi.org/10.1016/S2214-109X(24)00275-4 (2024).

    Article  CAS  PubMed  Google Scholar 

  28. Castilhos, R. M. et al. Population attributable fractions of modifiable dementia risk factors for cognitive impairment—the ELSA-Brasil cohort study. Lancet Reg. Health Am. 49, 101184 https://doi.org/10.1016/j.lana.2025.101184 (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  29. Baker, L. D. et al. Study design and methods: U.S. study to protect brain health through lifestyle intervention to reduce risk (U.S. POINTER). Alzheimers Dement. 20, 769–782 https://doi.org/10.1002/alz.13365 (2024).

    Article  PubMed  Google Scholar 

  30. Crivelli, L. et al. Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial. Lancet 408, 417–429 https://doi.org/10.1016/S0140-6736(26)01278-X (2026).

    Article  PubMed  Google Scholar 

  31. Breuer, E. et al. Beyond the project: building a strategic theory of change to address dementia care, treatment and support gaps across seven middle-income countries. Dementia 21, 204–228 https://doi.org/10.1177/14713012211029105 (2022).

    Article  Google Scholar 

  32. Hurzuk, S. et al. Understanding, experiences and attitudes of dementia in India: a qualitative study. Dementia 21, 2288–2306 https://doi.org/10.1177/14713012221118774 (2022).

    Article  PubMed  Google Scholar 

  33. Farina, N. et al. Description of the cross-cultural process adopted in the STRiDE (STrengthening Responses to dementia in DEveloping countries) program: a methodological overview. Alzheimers Dement. 14, e12293 https://doi.org/10.1002/dad2.1229 (2022).

    Article  Google Scholar 

  34. Prina, A. M. et al. Cohort profile: the 10/66 study. Int. J. Epidemiol. 46, 406–406i https://doi.org/10.1093/ije/dyw056 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  35. Ibanez, A. et al. The Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat): driving multicentric research and implementation science. Front. Neurol. 12, 631722 https://doi.org/10.3389/fneur.2021.631722 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank all participants and their families for their time, trust, and invaluable contributions to this study. We acknowledge Alzheimer Ibero América (AIB) and its Scientific Committee, as well as Alzheimer associations across Latin America and the Caribbean, for their support and engagement. We also recognize the contributions of regional research networks and initiatives, including the 10/66 Dementia Research Group, LatAm-FINGERS, the Latin America and Caribbean Consortium on Dementia (LAC-CD), and Strengthening responses to dementia (STRiDE project). We further thank all healthcare professionals, researchers, policymakers, caregivers, and members of the general public whose participation made this work possible.

Funding

This work was supported by the Alzheimer’s Association (24HPE-1287320 and ALZSI-25-1464205). The funders had no role in study design, data collection, data analysis, data interpretation, manuscript preparation, or the decision to submit the work for publication.

Author information

Author notes

  1. These authors contributed equally: Juan J. Llibre Rodriguez, Isaac Acosta.

Authors and Affiliations

  1. NeuroGlobal Health Initiative, St. Louis, MO, USA

    Juan J. Llibre Rodriguez & Ana M. Rodriguez Salgado

  2. Laboratory of the Dementias, National Institute of Neurology and Neurosurgery, Mexico City, Mexico

    Isaac Acosta, Marco Garcia & Ana Luisa Sosa

  3. Universidad Nacional Pedro Henriquez Ureña (UNPHU), Internal Medicine Department, Geriatric Section, Santo Domingo, Dominican Republic

    Daisy Acosta

  4. Internal Medicine Department, Geriatrics Program, School of Medicine, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico

    Ivonne Z. Jimenez-Velazquez

  5. Instituto de la Memoria Depresion y Enfermedades de Riesgo IMEDER, Lima, Perú

    Mariella Guerra

  6. Medicine Department, Caracas University Hospital, Faculty of Medicine, Universidad Central de Venezuela, Caracas, Venezuela

    Aquiles Salas

  7. Department of Family Medicine, Universidad Autonoma de Nuevo Leon, Monterrey, México

    Raúl Gutierrez-Herrera

  8. Dementia Research Unit. Medical University of Havana, Playa, Havana, La Habana, Cuba

    Tania Zayas

  9. Department of Cognitive Neurology, Fleni, Montañeses, CABA Buenos Aires, Argentina

    Lucia Crivelli & Gustavo Emilio Sevlever

  10. Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile

    Claudia Duran-Aniotz

  11. Global Brain Health Institute (GBHI), Trinity College Dublin (TCD), Dublin, Ireland

    Claudia Duran-Aniotz

  12. Fundación Familiares de Alzheimer, Aguascalientes, A.C, Alzheimer Ibero America (AIB), Aguascalientes, Mexico

    Bertha Quesada

  13. Care Policy and evaluation Centre, London School of economics and Political Science, London, UK

    Adelina Comas-Herrera

  14. Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK

    Matthew Prina

  15. Department of Neurology, Washington University School of Medicine, Saint Louis, MO, USA

    Jorge J. Llibre-Guerra

  16. Washington University School of Public Health, St. Louis, MO, USA

    Jorge J. Llibre-Guerra

Authors

  1. Juan J. Llibre Rodriguez
  2. Isaac Acosta
  3. Marco Garcia
  4. Ana Luisa Sosa
  5. Daisy Acosta
  6. Ivonne Z. Jimenez-Velazquez
  7. Mariella Guerra
  8. Aquiles Salas
  9. Raúl Gutierrez-Herrera
  10. Ana M. Rodriguez Salgado
  11. Tania Zayas
  12. Lucia Crivelli
  13. Gustavo Emilio Sevlever
  14. Claudia Duran-Aniotz
  15. Bertha Quesada
  16. Adelina Comas-Herrera
  17. Matthew Prina
  18. Jorge J. Llibre-Guerra

Contributions

All authors contributed to the development of the study protocol and methods. Study conceptualisation and oversight were led by J.J.L.R., I.A., M.G., and J.J.L.G. Data acquisition and site coordination were performed by I.A., A.L.S., D.A., I.Z.J., M.G., A.S., L.C., C.D., TZ., AR., G.E.S.,R.G., B.Q and J.J.L.R. Data curation and management were conducted by I.A. and M.G. Statistical analysis and interpretation were carried out by J.J.L.R., J.J.L.G., I.A., and M.G. The first draft of the manuscript was prepared by J.J.L.R., I.A., and J.J.L.G. All authors contributed to critical revision of the manuscript and provided important intellectual input. Project administration was led by J.J.L.R. Funding acquisition and supervision were undertaken by J.J.L.G. All authors had full access to the data and approved the final version of the manuscript. The corresponding author had final responsibility for the decision to submit for publication.

Corresponding author

Correspondence to Juan J. Llibre Rodriguez.

Ethics declarations

Competing interests

The authors declare no competing interests. Claudia Duran-Aniotz (CDA) is supported by grants from the Multi-partner consortium to expand dementia research in Latin America [ReDLat2, supported by Fogarty International Center (FIC), National Institutes of Health, National Institutes of Aging (R01 AG057234, R01 AG075775, R01 AG21051, R01 AG083799, CARDS-NIH, R01 AG057234), Alzheimer’s Association (SG-20-725707), Rainwater Charitable Foundation – The Bluefield project to cure FTD, and Global Brain Health Institute)], ANID/FONDECYT Regular (1210622 & 1250091), ANID/NAM22I0007, ANID/PIA/ANILLOS ACT210096, Alzheimer’s Association (AARGD-24- 1310017), ANID/FOVI240065, ANID/Proyecto Exploracion 13240170, Wellcome Leap CARE Program (Grant Number: CARE-2025-0883490149), CliCBrain (Horizon ID: 101236426), A2026019S BrightFocus Foundation Standard Award Program in Alzheimer’s Disease Research

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Llibre Rodriguez, J.J., Acosta, I., Garcia, M. et al. Dementia research priorities in Latin America and the Caribbean: findings from a multi-country stakeholder survey. npj Dement. 2, 94 (2026). https://doi.org/10.1038/s44400-026-00153-0

Download citation

  • Received: 26 April 2026

  • Accepted: 25 September 2026

  • Published: 14 October 2026

  • Version of record: 14 October 2026

  • DOI: https://doi.org/10.1038/s44400-026-00153-0

来源:Nature 健康护理主题 · nature.com